925P External validation of the CD8 radiomics signature as a prognostic marker in recurrent or metastatic head and neck cancer treated with nivolumab von Adrien, L., Even, C., Hano, J.B., Deny, N., Mitrea, D., Tao, Y., Lefebvre, G., Daste, A., Saada, E.B., Fayette, J., Blanchard, P., Cifliku, V., Talebi, F., Monard, L., Texier, M., Robert, C., Classe, M., Auperin, A., Deutsch, E., Sun, R.

Volltext

P13.14.A PREDICTION OF OVERALL SURVIVAL IN HIGH-GRADE GLIOMA USING MULTIPARAMETRIC MRI-BASED RADIOMICS. APPLICATION TO A MULTICENTER COHORT von YUSTE, C, Carré, A, Dautun, L, Satragno, C, Mrissa, L, Sambourg, K, Veres, C, Savanovic, M, Karakaya, Y, Hachemi, T, Cifliku, V, Jenny, C, Meyer, P, Jacob, J, Maingon, P, Bockel, S, Dhermain, F, Noël, G, Deutsch, E, Robert, C

Volltext

P11.79.B MULTICENTRE MULTI-COMPONENT DATA COLLECTION TO DEFINE NEW PREDICTORS OF RELAPSE IN HIGH GRADE GLIOMA von Mrissa, L, Satragno, C, Savanovic, M, Karakaya, Y, Yuste, C, Veres, C, Sambourg, K, Dautun, L, Hachemi, T, Cifliku, V, Le, A, Meyer, P, Jenny, C, Jacob, J, Bombezin Domino, A, Maingon, P, Bockel, S, Dhermain, F, Noël, G, Deutsch, E, Robert, C

Volltext